Whether it's neurons responding to electrical signals or plants stretching toward light, nature is filled with examples of biological materials that respond to their environment. Now, researchers want ...

Some treatments work better when a compound is released gradually, keeping its concentration within a useful range for longer. Engineered spider-silk materials are being investigated for precisely ...

Kennedy Jr. is taking on the fuzziest category in food science. You might know a tomato when you see one, but for the federal government, identifying one is harder. Is a tomato a fruit or a vegetable?

Emmy animation winners 2026: five juried Emmy picks from Primal, Eyes of Wakanda, The Mighty Nein, and Star Wars: Visions ...

At IFT FIRST 2026, the Institute of Technologists’ annual meeting and expo that recently took place in Chicago, suppliers ...

Contribution ACV -- $7 million, consisting of $5 million from the Gates Foundation for predictive toxicology and $2 million from Gates Ventures for battery research. Trailing Four-Quarter Hosted ...

For much of their history, historically Black colleges and universities (HBCUs) have been profoundly underfunded. Charged with educating generations of Black leaders while navigating segregation, ...

You can't escape ozone in a big city, but we can all work to make less of it. Dan Smith shows how combining three oxygen ...

NPs continue to yield first-in-class and best-in-class therapeutics, driving innovation across anti-infectives, oncology, and various other disease areas. A recent audit of global approvals from 2014 ...

In March, I accompanied an international team of scientists on an expedition to one of the deepest places that humans have ever visited, a few hours outside Johannesburg, South Africa. Before sunrise, ...

An illustration of the experimental concept shows how researchers study phases in quantum material. In the background, the uniform blue stripes are the dominant order, and the subtle red stripe ...

- Planned August sNDA Submission for Selinexor in Combination with Ruxolitinib in Myelofibrosis under the Accelerated Approval Pathway Remains on Track - - Planned sNDA for Selinexor plus Ruxolitinib ...